Clinical Trials Browser

Phase 2 × Breast Neoplasms × Oxaliplatin × Clear all

NCT01387295 2023-12-11

Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease

Phase 2 Completed

38 enrolled 11 charts

Breast Neoplasms

NCT00297596 2021-10-28

Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer

Phase 2 Completed

25 enrolled 6 charts

Breast Neoplasms, Neoplasm Metastasis

NCT01387373 2020-10-05

Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT00204776 2019-12-12

XELOX for Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00216021 2015-12-09

Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT01658033 2015-09-09

Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) Patients

Phase 2 Completed

Breast Neoplasms

NCT00159458 2014-05-22

Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer

Phase 2 Terminated

Breast Neoplasms

NCT00674206 2013-12-12

A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer

Phase 2 Terminated

6 enrolled 6 charts

Breast Neoplasms

NCT00527930 2013-10-10

TORCH

Phase 2 Completed

Breast Neoplasms

NCT00006121 2012-07-24

Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy

Phase 2 Terminated

Breast Neoplasms

NCT01528826 2012-02-08

NVBOX

Phase 2 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01351597 2011-05-11

STORM

Phase 2 Unknown

Breast Neoplasms

NCT00216073 2011-05-02

Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer

Phase 2 Terminated

Breast Neoplasms

NCT00403988 2008-11-04

Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma

Phase 2 Terminated

Breast Neoplasms